News & Updates

Low-dose IL-2 therapy safe, effective in moderate-to-severe bullous pemphigoid

03 Dec 2024

Low-dose interleukin 2 (IL-2) therapy may be used to treat moderate-to-severe bullous pemphigoid (BP), as shown by earlier treatment responses of patients in a recent study.

Low-dose IL-2 therapy safe, effective in moderate-to-severe bullous pemphigoid

03 Dec 2024

The role of antiviral in the management of patients at high-risk of severe COVID-19: An update of evidence

03 Dec 2024

At a dinner talk hosted by Pfizer on Tuesday, 20 August 2024 in Malaysia, Dr Christian Sandrock, a renowned professor from the UC Davis Medical Center discussed the role of antiviral drug nirmatrelvir/ritonavir in the management of patients at high-risk of coronavirus disease 2019 (COVID-19). The event was chaired by Dr Khairil Erwan Khalid, an infectious disease physician at Hospital Kuala Lumpur.

The role of antiviral in the management of patients at high-risk of severe COVID-19: An update of evidence

03 Dec 2024

People with epilepsy face high burden of psychiatric comorbidities

03 Dec 2024

Psychiatric disorders such as anxiety, depression, schizophrenia, autism spectrum disorder, and alcohol dependence, among others, are more prevalent among people with epilepsy than among those who do not have the neurological condition, according to the results of a meta-analysis.

People with epilepsy face high burden of psychiatric comorbidities

03 Dec 2024

ASEAN Health Primary Care Symposium: Bridging Research and Practice in Pharyngitis and GERD Treatment

03 Dec 2024

At the recent 1st ASEAN Health Primary Care Symposium jointly organised by Reckitt Malaysia and the Malaysian Medical Association, distinguished speakers from the region provided insights on managing upper respiratory tract infections and upper gastrointestinal reflux disease.

ASEAN Health Primary Care Symposium: Bridging Research and Practice in Pharyngitis and GERD Treatment

03 Dec 2024

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024 by

Daily transcutaneous electrical nerve stimulation (TENS) therapy using a wearable device holds promise in alleviating pain, fatigue, and gait alterations in individuals with long COVID, as shown in a pilot study.

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024

Food processing has no association with glycaemic index, load

02 Dec 2024

A recent study has found no difference in glycaemic index (GI) and glycaemic load (GL) between processing levels according to NOVA classification. However, GL is lower in ultraprocessed grains and vegetables than minimally processed foods (MPFs).

Food processing has no association with glycaemic index, load

02 Dec 2024

Low SBP predicts all-cause death in AF patients

02 Dec 2024 by

Individuals with atrial fibrillation (AF) and a systolic blood pressure (SBP) of <110 mm Hg appear to be at higher risk of all-cause death, suggests a study, noting however that SBP is not significantly associated with renal (dys)function.

Low SBP predicts all-cause death in AF patients

02 Dec 2024

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024

The overall utilization rates of SGLT2 inhibitors have increased among patients with type 2 diabetes (T2D) following the release of the 2022 American Diabetes Association (ADA) guidelines.

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024

Beer drinkers have it worse diet-wise than other alcohol drinkers

02 Dec 2024 by

Among consumers of different types of alcohol, those who consume beer only have the lowest dietary quality compared with those confined to wine or liquor intake or those who consume multiple types of alcohol, according to data presented at TLM 2024.

Beer drinkers have it worse diet-wise than other alcohol drinkers

02 Dec 2024

S1PR1 agonist a promising treatment for rheumatoid arthritis

02 Dec 2024

The selective agonist of sphingosine-1-phosphate receptor-1 (S1PR1), proximod, appears to be well tolerated and helps reduce blood lymphocyte count in patients with rheumatoid arthritis (RA), according to a phase I study.

S1PR1 agonist a promising treatment for rheumatoid arthritis

02 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Low-dose IL-2 therapy safe, effective in moderate-to-severe bullous pemphigoid

Low-dose IL-2 therapy safe, effective in moderate-to-severe bullous pemphigoid

The role of antiviral in the management of patients at high-risk of severe COVID-19: An update of evidence

The role of antiviral in the management of patients at high-risk of severe COVID-19: An update of evidence

People with epilepsy face high burden of psychiatric comorbidities

People with epilepsy face high burden of psychiatric comorbidities

ASEAN Health Primary Care Symposium: Bridging Research and Practice in Pharyngitis and GERD Treatment

ASEAN Health Primary Care Symposium: Bridging Research and Practice in Pharyngitis and GERD Treatment

Wearable TENS device may zap away pain, fatigue due to long COVID

Wearable TENS device may zap away pain, fatigue due to long COVID

Food processing has no association with glycaemic index, load

Food processing has no association with glycaemic index, load

Low SBP predicts all-cause death in AF patients

Low SBP predicts all-cause death in AF patients

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

Beer drinkers have it worse diet-wise than other alcohol drinkers

Beer drinkers have it worse diet-wise than other alcohol drinkers

S1PR1 agonist a promising treatment for rheumatoid arthritis

S1PR1 agonist a promising treatment for rheumatoid arthritis